GlaxoSmithKline plc just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though GlaxoSmithKline plc claims to own 32,005,260 shares. This represents 29.3% of Theravance.
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!
Other recent filings from the company include the following:
Theravance's Chief Accounting Officer just declared owning 24,104 shares of Theravance - Aug. 13, 2018
Departure of Directors or Certain - Aug. 8, 2018